HeliosX Group (Dermatica and MedExpress) Revenue and Competitors
Estimated Revenue & Valuation
- HeliosX Group (Dermatica and MedExpress)'s estimated annual revenue is currently $74.3M per year.
- HeliosX Group (Dermatica and MedExpress)'s estimated revenue per employee is $297,000
Employee Data
- HeliosX Group (Dermatica and MedExpress) has 250 Employees.
- HeliosX Group (Dermatica and MedExpress) grew their employee count by 8% last year.
HeliosX Group (Dermatica and MedExpress)'s People
Name | Title | Email/Phone |
---|
HeliosX Group (Dermatica and MedExpress) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $25.1M | 93 | -3% | N/A | N/A |
#2 | $35.6M | 132 | 3% | N/A | N/A |
#3 | $61.5M | 207 | 5% | N/A | N/A |
#4 | N/A | 0 | N/A | N/A | N/A |
#5 | $23M | 85 | -19% | £8.2M | N/A |
#6 | $7.1M | 33 | -8% | N/A | N/A |
#7 | $17.7M | 73 | -4% | N/A | N/A |
#8 | $150.5M | 446 | 9% | N/A | N/A |
#9 | $159.3M | 472 | 5% | N/A | N/A |
#10 | $122.9M | 364 | 6% | N/A | N/A |
What Is HeliosX Group (Dermatica and MedExpress)?
We are a group of health tech companies (dermatica.co.uk, medexpress.co.uk) under one umbrella, and a rapidly growing team of c.50 sitting in the heart of Shoreditch. We operate a number of brands and ventures in medical, dermatology, and nutritional supplement sectors. We service over half a million patients in the UK providing tailored consultation and personalised prescription services helping people treat a wide range of conditions. We are dedicated to improving the quality, accessibility and affordability of healthcare for every person on the planet.
keywords:N/AN/A
Total Funding
250
Number of Employees
$74.3M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $33M | 250 | -13% | N/A |
#2 | $39.9M | 250 | 3% | N/A |
#3 | $49.5M | 250 | N/A | N/A |
#4 | $49.5M | 250 | N/A | N/A |
#5 | $15M | 250 | N/A | N/A |